SmartHEALTH: preliminary results of an electrochemical measurement using a microfluidic-based cancer diagnostic instrument

Abstract

To address the high economic burden of the healthcare sector, prevention, early diagnosis and informed therapeutics are indispensable. Tests must be highly accurate and well integrated into the medical management process to avoid unnecessary treatments and stress to users. SmartHEALTH will address these complex issues by developing highly intelligent diagnostic technologies that are fully integrated into healthcare systems, optimizing their impact in management and work practice. Driven by key targeted applications in cancer diagnostics (breast, cervical and colorectal), the project will deliver prototype systems with the aim of moving instrumentation from a laboratory platform to portable devices localized at the “point of care”. The preliminary results for a fully automatic electrochemical measurement in serum are presented.